Hearing, Vision, and Dual Sensory Impairment in Australian Long-Term Care: Prevalence and Impact
Journal of the American Medical Directors Association · 2026-08 · 27 (8) · 106303
DOI: 10.1016/j.jamda.2026.106303 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the American Medical Directors Association, 2026-08. Verfasst von Piers Dawes und 3 weiteren Autor:innen. Beteiligte Einrichtung: UQ Centre for Health Services Research, The University of Queensland, Brisbane, Australia. Electronic address: p.dawes@uq.edu.au. Die Arbeit nennt 11 Literaturangaben. Gefördert von: National Health and Medical Research Council.
Themen: Langzeitpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- UQ Centre for Health Services Research, The University of Queensland, Brisbane, Australia. Electronic address: p.dawes@uq.edu.au.
- UQ Centre for Health Services Research, The University of Queensland, Brisbane, Australia.
- The University of Queensland Centre for Hearing Research (CHEAR), The University of Queensland, Brisbane, Australia.
Förderung
- National Health and Medical Research Council
Zitieren
APA
Dawes, P., El-Saifi, N., Chicoteau, A., & Gray, L. C. (2026). Hearing, Vision, and Dual Sensory Impairment in Australian Long-Term Care: Prevalence and Impact. Journal of the American Medical Directors Association, 27(8), 106303. https://doi.org/10.1016/j.jamda.2026.106303
Vancouver
Dawes P, El-Saifi N, Chicoteau A, Gray LC. Hearing, Vision, and Dual Sensory Impairment in Australian Long-Term Care: Prevalence and Impact. Journal of the American Medical Directors Association. 2026;27(8):106303. doi:10.1016/j.jamda.2026.106303
BibTeX
@article{Dawes2026,
author = {Dawes, Piers and El-Saifi, Najwan and Chicoteau, Antony and Gray, Leonard C},
title = {Hearing, Vision, and Dual Sensory Impairment in Australian Long-Term Care: Prevalence and Impact},
journal = {Journal of the American Medical Directors Association},
year = {2026},
volume = {27},
number = {8},
pages = {106303},
doi = {10.1016/j.jamda.2026.106303}
}
EUVIMED